Los Angeles Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Soon-Shiong’s NantCell Acquires Italian Stem Cell Firm

NantCell, the immuno-oncology subsidiary of billionaire Patrick Soon-Shiong’s growing NantWorks health care technology empire, has acquired tissue and stem cell engineering firm VivaBioCell. Terms of the deal were not disclosed.

Kite Teams Up for HPV Drugs

Biotech firm Kite Pharma Inc. announced Monday that it will partner with leading immunotherapy developer Bluebird Bio Inc. of Cambridge, Mass. to develop and commercialize drugs directed against a cancer-causing strain of the human papillomavirus, or HPV.

Monday Rundown: New CEO for Long Beach Hospitals, Gulfstream Accountant Sentenced for Embezzlement, Tutor Perini to Build Philadelphia Hotel

MemorialCare Health System has promoted John Bishop, chief financial officer of Long Beach Memorial hospital, Miller Children’s & Women’s Hospital Long Beach, Community Hospital Long Beach and Seaside Health Plan in Long Beach, to chief executive.

Angelenos Swept Up in Medicare Fraud Bust

The Department of Justice announced Thursday it has charged eight people in Los Angeles with bilking Medicare out of about $66 million.

Kythera Purchased for $2.1 Billion

Kythera Biopharmaceuticals, Inc. will be acquired by Allergan plc in a $2.1 billion buyout announced Wednesday.

Wednesday Rundown: Wage Hike Almost Official, Sundance Cinema Selling, Arrowhead Drug Gets ‘Orphan’ Incentives

Council OKs Wage Hike It’s almost officially official: The Los Angeles City Council has given final approval to a minimum wage hike in the city, sending the measure to the mayor’s desk.

FDA Recommends Amgen Cholesterol Drug

A regulatory advisory panel on Wednesday recommended approval for Repatha, a new cholesterol drug from Amgen Inc., although use should be limited to patients with high risk of heart disease.

FDA to Weigh Amgen’s Repatha

Health regulators have decided a new drug from Amgen Inc. reduces “bad” cholesterol, but they aren’t sure it’s for everyone.

Puma Tumbles After Presentation

Puma Biotechnology Inc. got a mixed reception from physicians Monday morning after the company shared additional data from its pivotal breast cancer drug trial at the American Society of Clinical Oncology’s annual meeting in Chicago.

Children’s Hospital Expands to Encino

Children’s Hospital Los Angeles on Monday opened a new outpatient care center in Encino, the Los Feliz institutions fifth outpost opened over the past few years. Opening satellite sites is a popular practice among local hospitals, which see them as a cheaper way to expand their services while also helping bring in more patients who are privately insured. See more on the hospital’s strategy in the latest edition of the Business Journal.

Amgen, Merck Expand Cancer Research

Amgen Inc. will expand its collaboration with Merck on research seeking a cure for a special type of head and neck cancer, the company announced Friday.

Friday Rundown: Puma Report On Tap, LAX Traffic Takeoff Continues, Zipcar and Metro Team Up

Puma to Unpack Drug Study Puma Biotechnology Inc. on Monday morning will reveal additional details from a pivotal study of its breast cancer drug at the American Society of Clinical Oncology’s annual meeting in Chicago.

Suicide Concerns Dissolve Amgen Partnership

Amgen Inc. will end a partnership to develop a drug for psoriasis because it could face restrictive labeling due to concerns from regulatory agencies that it might lead to suicidal thoughts.

E.U. Panel Backs Amgen Cholesterol Drug

Amgen Inc. announced Friday that a European Union committee has recommended approval of its drug Repatha to treat high cholesterol.

DaVita Consolidates in Large El Segundo Lease Deal

DaVita HealthCare Partners Inc. wanted to “DaVita-ize” its California presence.